- Home
- WHWK
as 11-11-2025 3:37pm EST
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MORRISTOWN |
| Market Cap: | 95.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 5.2M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.39 - $3.81 | Next Earning Date: | 11-06-2025 |
| Revenue: | $14,384,000 | Revenue Growth: | -42.63% |
| Revenue Growth (this year): | -71.96% | Revenue Growth (next year): | N/A |
Latest Whitehawk Therapeutics Inc. Common Stock News
WHWK Breaking Stock News: Dive into WHWK Ticker-Specific Updates for Smart Investing
PR Newswire
19 hours ago
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London
PR Newswire
6 days ago
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
Simply Wall St.
11 days ago
Hedge funds investors own a significant stake of 37% in Whitehawk Therapeutics, Inc. (NASDAQ:WHWK)
Simply Wall St.
15 days ago
Tempus AI-Whitehawk Therapeutics Data Partnership Could Be a Game Changer for Tempus AI (TEM)
PR Newswire
19 days ago
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC
Zacks
a month ago
Tempus AI Fuels Growth Through Strategic Biotech Collaborations
MT Newswires
a month ago
Whitehawk Shares Rise After Forming Collaboration With Tempus AI to Advance Oncology Research
Business Wire
a month ago
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
Compare WHWK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WHWK Whitehawk Therapeutics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.